Diabetes. 2005;54(10):2838-2843. We demonstrated that the CB-1 receptor is expressed in organs relevant to the pathogenesis of obesity in humans, so that results from mechanistic studies in animals ...
SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye"), a pharmaceutical company developing drugs targeting the endocannabinoid system, announced today that it plans ...
Cannabis, once a symbol of rebellion and counterculture, is now one of the most commonly used recreational substances. The plant’s primary psychoactive compounds, THC (tetrahydrocannabinol) and CBD ...
Phase 2 study in patients with obesity and chronic kidney disease planned to initiate in first half of 2024 SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (SKYE) ("Skye"), a ...